Literature DB >> 142536

Role of 5-hydroxytryptamine in morphine-, pethidine-, and methadone-induced hypothermia in rats at low ambient and room temperature.

T Oka.   

Abstract

1 The effect of morphine (10 or 20 mg/kg s.c.), pethidine (25 or 50 mg/kg s.c.) or methadone (4 or 8 mg/kg s.c.) on the body temperature of nontreated and p-chlorophenylalanine-pretreated rats was studied at room (21+/-0.2 degrees C) or low ambient (12+/-0.2 degrees C) temperature. 2 Neither pethidine nor smaller doses of morphine and methadone altered the mean rectal temperature of rats kept at room temperature but larger doses of morphine and methadone produced significant hypothermia. 3 All narcotic analgesics at doses used in the present investigation produced significant hypothermia in rats maintained in a low ambient temperature. The hypothermia was prevented by naloxone (1 mg/kg s.c.). 4 The administration of p-chlorophenylalanine (PCPA, 320 mg/kg i.p.) 48 h before the narcotic injection prevented the fall in body temperature both at room and low ambient temperature. 5 The administration of narcotic analgesics at doses, which when administered by themselves did not alter the body temperature of rats, produced significant hyperthermia in rats pretreated with PCPA. 6 When rats pretreated with PCPA were given 5-hydroxytryptophan (75 mg/kg s.c.) 30 min before narcotic administration, the usual response to narcotics was restored. 7 It appears that pethidine and methadone as well as morphine have both hyperthermic and hypothermic actions in rats and that 5-hydroxytryptamine may be involved in the narcotic-induced hypothermia not only at room temperature but also at low ambient temperature.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142536      PMCID: PMC1667286          DOI: 10.1111/j.1476-5381.1977.tb07503.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  The temperature response in rats during acute and chronic morphine administration, a study of morphine tolerance.

Authors:  L M GUNNE
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-12-31

2.  Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.

Authors:  T Oka; E Hosoya
Journal:  Psychopharmacology (Berl)       Date:  1976-06-23       Impact factor: 4.530

3.  Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines.

Authors:  A Carlsson; M Lindqvist
Journal:  J Pharm Pharmacol       Date:  1969-07       Impact factor: 3.765

4.  Abolition of the morphine effect on body temperature in midbrain raphe lesioned rats.

Authors:  R Samanin; S Kon; S Garattini
Journal:  J Pharm Pharmacol       Date:  1972-05       Impact factor: 3.765

5.  Effect of acutely administered analgesic drugs on rat brain serotonin turnover.

Authors:  I Goodlet; M F Sugrue
Journal:  Eur J Pharmacol       Date:  1974-12       Impact factor: 4.432

6.  Effects of p-chlorophenylalanine and cholinergic antagonists on body temperature changes induced by the administration of morphine to nontolerant and morphine-tolerant rats.

Authors:  T Oka; M Nozaki; E Hosoya
Journal:  J Pharmacol Exp Ther       Date:  1972-01       Impact factor: 4.030

7.  Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administration.

Authors:  G G Yarbrough; D M Buxbaum; E Sanders-Bush
Journal:  J Pharmacol Exp Ther       Date:  1973-05       Impact factor: 4.030

8.  Effects of narcotic analgesics on serotonin metabolism in brain of rats and mice.

Authors:  A Sawa; T Oka
Journal:  Jpn J Pharmacol       Date:  1976-10

9.  Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.

Authors:  D M Buxbaum; G G Yarbrough; M E Carter
Journal:  J Pharmacol Exp Ther       Date:  1973-05       Impact factor: 4.030

10.  The effect of p-chlorophenylalanine on the pethidine- or methadone-induced decrease in locomotor activity of rats.

Authors:  T Oka; K Hosoya
Journal:  Eur J Pharmacol       Date:  1976-06       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.